KIMBERLY TAYLOR: Open Payments
NPI 1447446471 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 8 payments from 8 companies in 2025. Trend: 2023 $56 · 2024 $1,165 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $108 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: MAVYRET, ZENPEP, Dexcom G6 Transmitter, LINQ II, LOREEV XR, XIFAXAN, REXULTI, GARDASIL 9.
Industry payments across AZ — which companies pay providers there.
